chitosan has been researched along with saquinavir in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernkop-Schnürch, A; Föger, F; Hoyer, H; Kafedjiiski, K; Loretz, B | 1 |
| Jadhav, P; Jain, V; Mishra, PR; Prasad, V | 1 |
| Krishnan, UM; Ramana, LN; Ranga, U; Sethuraman, S; Sharma, S | 1 |
3 other study(ies) available for chitosan and saquinavir
| Article | Year |
|---|---|
Enhanced transport of P-glycoprotein substrate saquinavir in presence of thiolated chitosan.
Topics: Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Chitosan; HIV Protease Inhibitors; Humans; Rats; Saquinavir; Substrate Specificity; Sulfhydryl Compounds | 2007 |
Preparation and performance evaluation of saquinavir laden cationic submicron emulsions.
Topics: Administration, Oral; Amines; Animals; Cations; Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Drug Stability; Emulsions; Excipients; HIV Protease Inhibitors; In Vitro Techniques; Intestinal Absorption; L-Lactate Dehydrogenase; Male; Particle Size; Protamines; Rats; Rats, Sprague-Dawley; Saquinavir; Toxicity Tests | 2009 |
Evaluation of chitosan nanoformulations as potent anti-HIV therapeutic systems.
Topics: Calorimetry, Differential Scanning; Chitosan; Drug Carriers; HEK293 Cells; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Jurkat Cells; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Phagocytosis; Saquinavir | 2014 |